Tumor Volumes and Prognosis in Laryngeal Cancer

Tumor staging systems for laryngeal cancer (LC) have been developed to assist in estimating prognosis after treatment and comparing treatment results across institutions. While the laryngeal TNM system has been shown to have prognostic information, varying cure rates in the literature have suggested concern about the accuracy and effectiveness of the T-classification in particular. To test the hypothesis that tumor volumes are more useful than T classification, we conducted a retrospective review of 78 patients with laryngeal cancer treated with radiation therapy at our institution. Using multivariable analysis, we demonstrate the significant prognostic value of anatomic volumes in patients with previously untreated laryngeal cancer. In this cohort, primary tumor volume (GTVP), composite nodal volumes (GTVN) and composite total volume (GTVP + GTVN = GTVC) had prognostic value in both univariate and multivariate cox model analysis. Interestingly, when anatomic volumes were measured from CT scans after a single cycle of induction chemotherapy, all significant prognosticating value for measured anatomic volumes was lost. Given the literature findings and the results of this study, the authors advocate the use of tumor anatomic volumes calculated from pretreatment scans to supplement the TNM staging system in subjects with untreated laryngeal cancer. The study found that tumor volume assessment after induction chemotherapy is not of prognostic significance.

[1]  F. Hilgers,et al.  Variability of tumor volumes in T3‐staged head and neck tumors , 1997, Head & neck.

[2]  R. Knecht,et al.  State of the art in the treatment of laryngeal cancer. , 2013, Anticancer research.

[3]  W. Mendenhall,et al.  Management of T1–T2 glottic carcinomas , 2004, Cancer.

[4]  J. Bussink,et al.  PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging , 2015, Clinical Cancer Research.

[5]  R. Müller,et al.  [Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas]. , 2000, HNO (Berlin. Print).

[6]  A. Baert,et al.  Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  M C Gilardi,et al.  PET/CT and radiotherapy. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[8]  N. Hall,et al.  Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer Patients , 2007, The Laryngoscope.

[9]  Sandra Nuyts,et al.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.

[10]  B. Guerrier,et al.  Assessment of laryngeal cancer: CT scan versus endoscopy. , 1989, The Journal of otolaryngology.

[11]  S. Zeitels,et al.  Endoscopic treatment of supraglottis and hypopharynx cancer , 1994, The Laryngoscope.

[12]  S. Mukherji,et al.  Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone? , 1995, AJNR. American journal of neuroradiology.

[13]  B. Branstetter,et al.  Indications for PET/CT in the head and neck. , 2008, Otolaryngologic clinics of North America.

[14]  A. Eisbruch,et al.  Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. , 2013, Oral oncology.

[15]  J. Horiot,et al.  The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  S. Ghaffar,et al.  Association between tumour volume and recurrence of squamous cell carcinoma of the head and neck. , 2012, JPMA. The Journal of the Pakistan Medical Association.

[17]  A. Hasman,et al.  Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. , 1987, International journal of radiation oncology, biology, physics.

[18]  D. Chua,et al.  Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. , 1997, International journal of radiation oncology, biology, physics.

[19]  E Bellon,et al.  Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. , 1998, International journal of radiation oncology, biology, physics.

[20]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[21]  E. Vokes Competing roads to larynx preservation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  W. Shockley,et al.  Use, Accuracy, and Implications for Patient Management of [18F]‐2‐Fluorodeoxyglucose‐Positron Emission/Computerized Tomography for Head and Neck Tumors , 2005, The Laryngoscope.

[23]  M. Castillo,et al.  The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx , 2000, Head & neck.

[24]  W. Mendenhall T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. , 1998, Seminars in radiation oncology.

[25]  M. Remacle,et al.  Endoscopic Partial Supraglottic Laryngectomies , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  Alicia Y Toledano,et al.  Interobserver reliability of computed tomography‐derived primary tumor volume measurement in patients with supraglottic carcinoma , 2005, Cancer.

[27]  W. Mendenhall,et al.  Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck , 2003, Head & neck.

[28]  W. Hong,et al.  Larynx Preservation Using Induction Chemotherapy plus Radiation Therapy as an Alternative to Laryngectomy in Advanced Head and Neck Cancer A Long‐Term Follow‐up Report , 1991, American journal of clinical oncology.

[29]  H. Joensuu,et al.  Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Regina O Redfern,et al.  Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. , 2004, AJNR. American journal of neuroradiology.

[31]  Xavier Geets,et al.  Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  W. Mendenhall,et al.  Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? , 1997, International journal of radiation oncology, biology, physics.

[33]  A. Herneth,et al.  Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. , 2003, European journal of radiology.

[34]  R. Weber,et al.  Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival , 2006, The Laryngoscope.

[35]  J. Shah,et al.  TNM Staging of Cancers of the Head and Neck: Striving for Uniformity Among Diversity , 2005, CA: a cancer journal for clinicians.

[36]  G Motta,et al.  T1-T2-T3 glottic tumors: fifteen years experience with CO2 laser. , 1997, Acta oto-laryngologica. Supplementum.

[37]  S. Stringer,et al.  Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  D. Adelstein,et al.  Long‐Term Results After Chemoradiotherapy for Locally Confined Squamous‐Cell Head and Neck Cancer , 1990, American journal of clinical oncology.

[39]  K. Greven,et al.  Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. , 1997, International journal of radiation oncology, biology, physics.

[40]  M. Nakata,et al.  The results of radiation therapy for glottic carcinoma: prognostic significance of tumor size in laryngoscopic findings. , 2000, Oncology reports.

[41]  H. S. Hansen,et al.  The prognostic importance of volume‐weighted mean nuclear volume, mitotic index, and other stereologically measured quantitative parameters in supraglottic laryngeal carcinoma , 1999, Cancer.

[42]  K. Greven,et al.  Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma , 2001, Head & neck.

[43]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Boring,et al.  Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.

[45]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  T. Hothorn,et al.  Multiplanar functional imaging of the larynx and hypopharynx with multislice spiral CT , 2004, European Radiology.

[47]  W. Mendenhall,et al.  Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? , 1990, International journal of radiation oncology, biology, physics.

[48]  R J Sanderson,et al.  Squamous cell carcinomas of the head and neck. , 2002, BMJ.

[49]  P. Span,et al.  Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: results of the phase 3 ARCON trial. , 2014, European journal of cancer.

[50]  B. Maciejewski,et al.  Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer , 2013, Strahlentherapie und Onkologie.

[51]  G. Masters,et al.  Overview of head and neck cancer. , 2003, Cancer treatment and research.

[52]  George Fountzilas,et al.  Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. , 2004, International journal of radiation oncology, biology, physics.

[53]  J. Greenman,et al.  Radioresistant laryngeal cancer: beyond the TNM stage. , 2004, Clinical otolaryngology and allied sciences.

[54]  C. Borel,et al.  Prognostic indicators for survival in head and neck squamous cell carcinomas: Analysis of a series of 621 cases , 2005, Head & neck.

[55]  H Steininger,et al.  Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  L. Harrison,et al.  Long-term Follow-up and Pattern of Failure for T1-T2 Glottic Cancer After Definitive Radiation Therapy , 2013, American journal of clinical oncology.

[57]  G. Lockwood,et al.  Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  D. Stojanov,et al.  Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer. , 2012, Collegium Antropologicum.

[59]  A. Dietz,et al.  Prognostischer Stellenwert des Hämoglobinwertes vor primärer Radiochemotherapie von Kopf-Hals-Karzinomen , 2000, HNO.

[60]  J. Shah,et al.  Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. , 2012, International journal of radiation oncology, biology, physics.

[61]  I. Doweck,et al.  Tumor Volume Predicts Outcome for Advanced Head and Neck Cancer Treated With Targeted Chemoradiotherapy , 2002, The Laryngoscope.

[62]  P. Warde,et al.  A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. , 2002, Journal of clinical epidemiology.

[63]  R. Fisher,et al.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  D. Wazer,et al.  The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. , 1995, International journal of radiation oncology, biology, physics.

[65]  L. Kowalski,et al.  Prognostic Factors in Supraglottic Carcinoma Patients Treated by Surgery or Radiotherapy , 1998, The Annals of otology, rhinology, and laryngology.

[66]  T. Rutkowski Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer , 2014, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[67]  H. Raitiola,et al.  Radiotherapy outcome and prognostic factors in early glottic carcinoma. , 2000, Auris, nasus, larynx.

[68]  M. Bernal-Sprekelsen,et al.  CO2 laser surgery: A larynx preservation alternative for selected hypopharyngeal carcinomas , 2004, Head & neck.

[69]  S. Coulthard,et al.  Radiation Therapy for Squamous Cell Carcinoma of the Supraglottic Larynx , 1989, American journal of clinical oncology.

[70]  S. Mukherji,et al.  Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  W. Hong,et al.  Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. , 1996, Archives of otolaryngology--head & neck surgery.

[72]  M. Csanády,et al.  Transoral CO2 laser management for selected supraglottic tumors and neck dissection , 2011, European Archives of Oto-Rhino-Laryngology.

[73]  L. Collette,et al.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.

[74]  V. Rousson,et al.  Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT , 2007, Acta oncologica.

[75]  W. Mendenhall,et al.  Time-dose factors in positive neck nodes treated with irradiation only. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[76]  W. Sheils,et al.  The Effect of treatment on survival in patients with advanced laryngeal carcinoma , 2009, The Laryngoscope.

[77]  M. Suntharalingam,et al.  Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[78]  V. Yeager,et al.  Improved diagnostic accuracy in laryngeal cancer using a new classification based on computed tomography , 1984, Cancer.

[79]  Robert Hermans,et al.  Staging of laryngeal and hypopharyngeal cancer: value of imaging studies , 2006, European Radiology.

[80]  S. Mukherji,et al.  Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion , 2009, The Laryngoscope.

[81]  M. Kron,et al.  Organ Preservation by Transoral Laser Microsurgery in Piriform Sinus Carcinoma , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[82]  M. Hjelm-Hansen Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model. , 1980, Acta radiologica. Oncology.

[83]  W. Mendenhall,et al.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  Michael Baumann,et al.  Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[85]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[86]  N. Aygun,et al.  Radiologic evaluation of larynx cancer. , 2008, Otolaryngologic clinics of North America.

[87]  V. Yeager,et al.  The Degree to Which Accuracy of Preoperative Staging of Laryngeal Carcinoma has been Enhanced by Computed Tomography , 1986, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[88]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[89]  E. Babin,et al.  Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008. , 2015, European annals of otorhinolaryngology, head and neck diseases.